Rio de Janeiro, Brazil — KAVI–Institute of Clinical Research (KAVI-ICR), University of Nairobi, strengthened its global engagement in HIV vaccine research through active participation at AIDS 2026, the 26th International AIDS Conference, held in Rio de Janeiro, Brazil, from 26 to 31 July 2026 under the theme “Rethink. Rebuild. Rise.”
On 29 July 2026, the KAVI Institute of Clinical Research (KAVI-ICR) at the University of Nairobi hosted a ThermoFisher Innovation Day, welcoming a delegation from Scientific Laboratory Supplies (SLS) and Thermo Fisher Scientific together with scientists from Partners for Health and Development in Africa (PHDA) and the University of Nairobi's Faculty of Health Sciences.
Clinical and laboratory teams from Mbagathi County Hospital and Loitokitok Sub-County Hospital completed a week of intensive training before the dry run on 10 July 2026.
The Kenyan arm of the ZAFI study reached an important milestone this month with a five-day site initiation and training programme at KAVI-ICR in Nairobi.
KAVI-Institute of Clinical Research (KAVI-ICR) was represented at the joint meeting of the Centralized Lab Network (CLN) and the Preclinical Model Network (PMN), held in Cape Town, South Africa, in June 2026. The institute was represented by its founding Director, Prof. Omu Anzala, and Dennis Chalo, reaffirming KAVI-ICR's commitment to advancing global vaccine research through strategic international collaboration.
KAVI-Institute of Clinical Research (KAVI-ICR) proudly congratulates Joel Musando and Naomi Mwakishi for representing the institute at the Keystone Symposium on Viral Pathogenesis and Immunity in Hannover, Germany, after receiving the prestigious Global Health Travel Award.
The KAVI-Institute of Clinical Research (KAVI-ICR) proudly celebrates a landmark achievement by its Director, Prof. Marianne Wanjiru Mureithi, following her promotion to the rank of Professor by the University of Nairobi.
This promotion marks a historic milestone as Prof. Mureithi becomes the first woman in the history of the Department of Medical Microbiology & Immunology to attain the rank of Professor.
Every year, hundreds of women and men walk into Kenyatta National Hospital (KNH) with breast, ovarian, or prostate cancer. Some of them carry a BRCA1 or BRCA2 mutation, a genetic marker that could open the door to life-extending treatment but many may never know. The test that would tell them is cost-prohibitive, and it is not routinely offered in public hospitals in Kenya.
KAVI-ICR was pleased to host Prof. Rose Jepchumba Kosgei, newly appointed Associate Dean, Undergraduate Studies, Faculty of Health Sciences, during a courtesy visit to the Institute.
The visit brought together KAVI-ICR leadership and newly elected student leaders from the Faculty of Health Sciences and UNSA for an engaging discussion on mentorship, research exposure, academic growth and opportunities for continued collaboration.
University of Nairobi researchers and leadership joined national stakeholders at the Science, Technology, Research and Innovation for Society (STRI4Society) Week 2026 held at the Kenyatta International Convention Centre (KICC), Nairobi.
The week-long forum brought together policymakers, scientists, innovators, academia, industry and development partners to advance conversations on the role of science, research, technology and innovation in national development.
KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, is proud to highlight the participation of Prof Omu Anzala at the World Health Summit Regional Meeting 2026.
